skip to Main Content
+389 (0) 2 3298 295 healthrights@esem.org.mk

WHO recommends dolutegravir as preferred HIV treatment

Извор: Светска здравствена организација – 22.07.2019 Based on new evidence assessing benefits and risks, WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, including pregnant women and those of…

Повеќе

1,000 life-changing days

Извор: EuroHealthNet – 04.07.2019 This new video from EuroHealthNet explores the effects of social, emotional, and physical environments during the first three years of life on long-term health and wellbeing. It looks at the actions needed to create solid foundations…

Повеќе
Back To Top